Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P2BY
|
|||
| Former ID |
DNC009296
|
|||
| Drug Name |
[2-(Benzoimidazol-1-yl)ethyl]-bisphosphonic acid
|
|||
| Synonyms |
CHEMBL457423; AC1NQQY7; [2-(Benzoimidazol-1-yl)ethyl]-bisphosphonic acid; [2-(benzoimidazol-1-yl)ethylidene]bisphosphonic acid; SCHEMBL20385726; BDBM50273716; 847738-31-2; [2-(benzimidazol-1-yl)-1-phosphonoethyl]phosphonic acid; Phosphonic acid, [2-(1H-benzimidazol-1-yl)ethylidene]bis-; [2-(benzimidazol-1-yl)-1-phosphono-ethyl]phosphonic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H12N2O6P2
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)N=CN2CC(P(=O)(O)O)P(=O)(O)O
|
|||
| InChI |
1S/C9H12N2O6P2/c12-18(13,14)9(19(15,16)17)5-11-6-10-7-3-1-2-4-8(7)11/h1-4,6,9H,5H2,(H2,12,13,14)(H2,15,16,17)
|
|||
| InChIKey |
ISSICOMKRRPVPD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Geranyltranstransferase (FDPS) | Target Info | Inhibitor | [1] |
| BioCyc | Superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) | |||
| Superpathway of cholesterol biosynthesis | ||||
| Trans, trans-farnesyl diphosphate biosynthesis | ||||
| Geranylgeranyldiphosphate biosynthesis | ||||
| KEGG Pathway | Terpenoid backbone biosynthesis | |||
| Metabolic pathways | ||||
| Biosynthesis of antibiotics | ||||
| Influenza A | ||||
| HTLV-I infection | ||||
| NetPath Pathway | TCR Signaling Pathway | |||
| Panther Pathway | Cholesterol biosynthesis | |||
| Pathwhiz Pathway | Steroid Biosynthesis | |||
| Reactome | Cholesterol biosynthesis | |||
| Activation of gene expression by SREBF (SREBP) | ||||
| WikiPathways | Activation of Gene Expression by SREBP (SREBF) | |||
| SREBP signalling | ||||
| Cholesterol Biosynthesis | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocy... J Med Chem. 2008 Nov 13;51(21):6800-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.